The 17th Annual Conference of Saudi Society of Medical Microbiology and Infectious Diseases

Introduction

Take This Event

The Saudi Conference of Infectious Diseases and Microbiology is the only annual meeting in the Kingdom and is designed to meet the needs of health professionals, particularly physicians, clinical microbiologists, researchers, and pharmacists, specializing in infectious diseases.

This year the conference is continuing for shooting one of the major outbreak infection that still effected both health care workers and public; SARS CoV-2 (COVID-19), in addition to the other pathogens that have an important impact to the healthcare services such as Antimicrobial Resistance Organisms.

Several papers will be presented national and international to improve and manage these infections in our community and healthcare facilities.

Objectives

1- Discuss the current situation for prevention and control of COVID-19 and the latest preparedness on Ebola infection in the Kingdom of Saudi Arabia, in addition to the other emerging infectious diseases around the globe to achieve 100% compliance from the majority of the health care in the kingdom of Saudi Arabia.

2- Facilitate the exchange of new information among healthcare professionals, particularly infectious diseases specialists, clinical microbiologists, infection preventionists, physicians, critical care specialists, researchers, nurses, pharmacists and trainees specializing in infectious diseases which will have more than 95% impact on their practice.
3- Address the challenges that are facing the diagnosis and management of new emerging infections and providing at least more than 95% to over-come about this challenges.
4- To review topics including new international and domestic perspectives on infection management, antimicrobial stewardship and new technologies that have been developed to improve the diagnosis of diseases.
5- Translation for more than 95% of research and epidemiologic data into quality improvement practices toward patient safety.
6- How can we help in slowdown evolving resistance for up to 60% ?
7- Improve at least 80% on the challenges in Diagnosing TB In smear negative patients and extra-pulmonary sites of infection.
8- Discussing the core elements of Antimicrobial Stewardship (ASP) in healthcare facility focusing on the Approach to plan and perform ASP Intervention by achieving 80-90% for appropriate use of antibiotics.
9- Assuring 100% Laboratory Safety and specimen management.
10- Up to what percent COVID-19 Vaccine rollout in pandemics and future application on novel vaccination technologies.
11- Does the current status for Monoclonal antibodies and convalescent plasma achieve 80% to cure from the complication of SARS-CoV-2 infection.